Skip to main content
. 2017 Dec 22;9(15):12323–12332. doi: 10.18632/oncotarget.23617

Table 2. HRs and 95% CIs for patient survival or disease progression in association with TRIM29 expression in enrolled studies.

First author, publication year Main assay method Case number OS DFS/RFS PFS/MFS
High expression low expression Total HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
Xu, 2017 qRT-PCR 41 15 56 1.400 (0.680–2.860) 0.026 1.300 (0.540–3.150) 0.030 NM NM
Xu, 2016 IHC 62 88 150 3.076 (1.544–6.129) 0.001 2.830 (1.495–5.356) 0.001 NM NM
Song, 2015 IHC 79 241 320 2.102 (1.069–3.193) 0.003 1.384 (0.982–1.952) 0.064 NM NM
Harris, 2015 qRT-PCR NM NM 43 0.210 (1.069–3.193) 0.006 NM NM 0.024
(0.003–0.909)
0.000
Harris, 2015 IHC NM NM 43 0.260 (0.120–0.580) 0.000 NM NM 0.154
(0.027–0.909)
0.000
Sun, 2014 IHC 109 77 186 2.180 (1.324–4.198) 0.011 1.630 (1.180–2.260) 0.008 NM NM
Jiang, 2013 IHC 65 86 151 0.431 (0.220-0.841) 0.014 2.370 (1.203–4.651) < 0.001 NM NM
Fristrup, 2013 IHC NM NM 283 0.810 (0.500–1.290) 0.366 NM NM 0.600
(0.390–0.930)
0.023
Fristrup, 2013 IHC NM NM 576 0.795 (0.505–1.251) 0.321 NM NM 0.790
(0.510–1.250)
0.321
Lai, 2013 IHC 25 34 59 2.558 (1.435–4.566) < 0.01 NM NM NM NM
Zhou, 2011 IHC NM NM 56 5.300 (1.32–20.774) 0.017 NM NM NM NM
Zhao, 2012 IHC NM NM 42 1.950 (1.260–3.030) 0.044 NM NM NM NM
Kosaka, 2007 qRT-PCR 62 62 124 1.050 (0.780–1.440) 0.730 NM NM NM NM

OS, overall survival; DFS, disease-free survival; MFS, metastasis-free survival; RFS, recurrence-free survival; PFS, progression-free survival; DSS, disease-specific survival; NSCLC, non-small cell lung cancer; OCSCC, oral cavity squamous cell carcinoma; SCC, squamous cell carcinoma; HR, hazard ratio; IHC, Immunohistochemistry; qRT-PCR, quantitative reverse transcription polymerase chain reaction; NM: not mentioned; CI, confidence interval; TRIM29, tripartite motif-containing protein 29.